Zynex P/FCF
Mi az Zynex P/FCF?
A P/FCF az Zynex, Inc. - 33.36
Mi a P/FCF meghatározása?
A szabad cash flow (P / FCF) ára egy olyan értékelési mutató, amely összehasonlítja a vállalat jelenlegi részvényárfolyamát az egy részvényre jutó szabad cash flow-val.
Price to free cash flow (P/FCF) is a measure that value investors find useful to analyze a company’s finances in relation to its current stock price. It is a stricter measure than the price to cash flow ratio as it subtracts capital expenditures from cash flow.
Free cash flow relies heavily on the state of a company's cash from operations, which is in turn heavily influenced by the company's net income. Companies can manipulate their free cash flow by lengthening the time they take to pay their bills, shortening the time it takes to collect what's owed to them, and putting off buying inventory. It also depends on what items are considered capital expenditures and this can be different in case of different companies.
Lower values of P/FCF generally indicate a company that is undervalued and whose stock is relatively cheap in relation to its free cash flow. Conversely, higher P/FCF indicate that the company's stock is relatively overvalued. Value investors thus favor companies with low or decreasing price to free cash flow values that indicate high or increasing free cash flow totals and relatively low stock share prices.
It is best to compare price to free cash flow ratios between similar companies in the same industry. However, the P/FCF metric can also be viewed over a longer time frame to see if the company's cash flow to share price value is improving or declining.
P/FCF a Health Care szektor a EURONEXT-on cégekben a Zynex -hoz képest
Mit csinál Zynex?
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and knee braces for knee support. Further, it offers Zynex Fluid Monitoring System (CM-1500), a fluid volume monitor, which is a non-invasive medical device for monitoring relative fluid volume changes used in operating and recovery rooms to detect fluid loss during surgery and internal bleeding during recovery; Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.
p/fcf -hoz hasonló cégek Zynex
- Dollar General nak P/FCF 33.27 van
- Flir Systems nak P/FCF 33.30 van
- Shoals Technologies nak P/FCF 33.30 van
- Dadi International nak P/FCF 33.30 van
- Guangdong Adway Construction () nak P/FCF 33.31 van
- Lemaitre Vascular Inc nak P/FCF 33.32 van
- Zynex nak P/FCF 33.36 van
- Dewhurst plc nak P/FCF 33.37 van
- Mack-Cali Realty nak P/FCF 33.37 van
- Pacific Mercantile Bancorp nak P/FCF 33.37 van
- Matador Resources Co nak P/FCF 33.38 van
- Mirvac Stapled Securities nak P/FCF 33.39 van
- Atrium European Real Estate nak P/FCF 33.40 van